Full Text View
Tabular View
Study Results
Related Studies
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer
This study has been completed.
Study NCT00486954   Information provided by GlaxoSmithKline

First Received on June 13, 2007.   Last Updated on January 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms, Gastrointestinal Tract
Additional conditions recognized in this trial
Digestive System Neoplasms
Gastrointestinal Neoplasms
Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Neoplasms by Site
Stomach Diseases
Interventions listed in this trial
Lapatinib
Paclitaxel
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services